Methods of Wound Debridement – October Cohort
Freeman Hospital (FH), Newcastle upon Tyne, Tyne and Wear, NE7 7DNThis two-day course will teach the different methods of wound debridement, with a special focus on conservative sharp debridement, facilitated by the Newcastle Hospitals’ Tissue Viability Team with guest speakers from Dermatology, Plastics, Podiatry and from Newcastle University.
Improving clinical practice in Congenital Heart Disease (CHD) – November 2023 cohort
Freeman Hospital (FH), Newcastle upon Tyne, Tyne and Wear, NE7 7DNThis 5 day course aims to provide learners with the knowledge and skills necessary to manage the care of a patient with congenital heart disease throughout their lifetime, allowing healthcare professionals to develop vital skills and knowledge to manage the care of patients with complex anatomy and physiology.
Introduction to cancer biology, targeted and immunotherapies – November 2023
Virtual delivery via MS TeamsThis course introduces the biology of cancer, the faulty genes that drive its behaviour, and the science behind systemic treatments including immunotherapies and precision medicine.
Methods of Wound Debridement – December Cohort
Freeman Hospital (FH), Newcastle upon Tyne, Tyne and Wear, NE7 7DNThis two-day course will teach the different methods of wound debridement, with a special focus on conservative sharp debridement, facilitated by the Newcastle Hospitals’ Tissue Viability Team with guest speakers from Dermatology, Plastics, Podiatry and from Newcastle University.
The 4Ps Researcher Development Programme – Cohort 4 – Jan-May 2024
Freeman Hospital (FH), Newcastle upon Tyne, Tyne and Wear, NE7 7DNThe 4Ps Programme has been developed by Newcastle's Nurses, Midwives and Allied Health Professionals and designed to support your needs no matter where you are on the “research interested” to “Aspiring Clinical Academic” continuum.
Advanced training on cancer biology, targeted and immunotherapies – January 2024
A five day course covering the biology, science and mechanisms behind the diverse range of targeted drug treatments and new immunotherapies for cancer with an overview of how they work – focusing on the science behind them – and giving descriptions of which treatments are relevant to each of the most common solid tumours and haematological cancers.